On Monday, Boeing Co (NYSE:BA)’s shares declined -0.13% to $134.43.
Boeing [BA] declared that Oman Air has contracted for a suite of services to support the forthcoming entry into service of the airline’s 787 Dreamliners and to ensure ongoing efficiency and cost savings for its fleet.
Boeing will support Oman Air’s 787s with its Component Services (formerly Rotables Exchange) program, Loadable Software Airplane Parts service and Airplane Health Administration. Together, these services will assist Oman Air minimize the time and cost of maintenance while increasing airplane availability.
With the Component Services program, Oman Air will have access to a Boeing-managed, dedicated pool of high-value, mission-critical parts, enabling the airline to greatly reduce their inventory administration costs while improving component availability.
The Boeing Company, together with its auxiliaries, designs, develops, manufactures, sells, services, and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight, and launch systems and services worldwide. The company operates in five segments: Commercial Airplanes, Boeing Military Aircraft, Network & Space Systems, Global Services & Support, and Boeing Capital. The Commercial Airplanes segment develops, produces, and markets commercial jet aircraft for various passenger and cargo requirements, in addition to provides related support services to the commercial airline industry.
Ciena Corporation (NYSE:CIEN)’s shares dropped -0.50% to $21.91.
TCR Telecom in Rio de Janeiro, Brazil has deployed a new municipal network with packet networking platforms from Ciena® (CIEN). The network supports the revitalization of Rio’s port region, which seeks to re-integrate the port region into the city of Rio de Janeiro by revitalizing more than 1,200 acres in the downtown neighborhoods of Gamboa, Santo Cristo and Saúde, by providing high-speed connectivity that enhances the attractiveness of commercial space, supports residential growth and the opening of new tourist attractions. It provides greater access to a high-capacity, low-latency and resilient network that is capable of delivering carrier-grade services, such as premium Gigabit Ethernet (GigE) services, to businesses and data centers in “Porto Maravilha.”
Key Facts:
- TCR Telecom operates an open-access fiber network that allows multiple service providers to leverage the network to provide high bandwidth connectivity to end users.
- As areas of the port are revitalized, public infrastructure, counting fiber connections, are constructed and installed in order to provide 100 percent coverage to residences and businesses, allowing for telecom services to be offered as a basic utility, like water or power. Each business will be able to access 1 Gb/s of connectivity on this low-latency network, through the service provider of their choice. Advanced multi-Gigabit Ethernet Business services, such data center connectivity and high-performance Internet access, are also accessible to the businesses located within the network footprint.
Ciena Corporation provides equipment, software, and services that support the transport, switching, aggregation, service delivery, and administration of voice, video, and data traffic on communications netoperates worldwide. The company’s Converged Packet Optical segment offers networking solutions optimized for the convergence of coherent optical transport, OTN switching, and packet switching. Its products comprise the 6500 Packet-Optical Platform, 5430 Reconfigurable Switching System, CoreDirector Multiservice Optical Switches, and OTN configuration for the 5410 Reconfigurable Switching System.
At the end of Monday’s trade, Biogen Inc (NASDAQ:BIIB)‘s shares surged 0.27% to $316.23.
Biogen (BIIB) has been named the biotechnology industry leader on the Dow Jones Sustainability World Index (DJSI World) for the second year in a row, after becoming the first U.S.-based biotech company to make the list in 2013. The company was also named to the Dow Jones Sustainability Index North America for the sixth successive year, one of only three biotech companies comprised of.
DJSI World tracks the economic, environmental and social strategy and performance of the 2,500 largest companies in the S&P Global Broad Market IndexSM. Of the 317 companies that were named to DJSI World, Biogen led the biotechnology industry, scoring in the 100th percentile on 17 of the 24 overall evaluation criteria, counting those addressing patient access to treatments, environment and innovation.
Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. It provides AVONEX to treat relapsing multiple sclerosis (MS); TYSABRI to treat relapsing forms of MS and Cohn’s disease; PLEGRIDY to treat relapsing MS; TECFIDERA to treat MS; FAMPYRA to improve walking in adult patients with MS; ALPROLIX to treat hemophilia B; ELOCTATE to treat hemophilia A; RITUXAN for treating non-Hodgkin’s lymphoma, rheumatoid arthritis, and chronic lymphocytic leukemia (CLL), in addition to two forms of ANCA-associated vasculitis; GAZYVA for the treatment of patients with formerly untreated CLL; and FUMADERM to treat severe plaque psoriasis in adult patients.
Laboratory Corp. of America Holdings (NYSE:LH), ended its Monday’s trading session with -0.19% loss, and closed at $118.29.
Laboratory Corporation of America® Holdings (LH) declared that for the period of September 12, 2015 to March 11, 2016, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms of the Zero Coupon Notes, accrue contingent cash interest at a rate of no less than 0.125% of the average market price of a Zero Coupon Note for the five trading days ended September 9, 2015, in addition to the continued accrual of the original issue discount. Contingent cash interest, which the Company has determined to be about $1.98 per Note, will be payable to holders of the Zero Coupon Notes as of the record date, which is February 25, 2016. The payment of contingent cash interest is predictable to be made on March 11, 2016.
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, STD tests, HCV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by the medical profession in core testing, patient diagnosis, and in the monitoring and treatment of diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
